Valuation: MediPal Holdings Corporation

Market Cap 640B 4.05B 3.6B 3.34B 3.04B 5.73B 385B 5.82B 40.12B 15.73B 201B 15.21B 14.88B P/E 2027 *
13.9x
P/E 2028 * 13.3x
Enterprise Value 640B 4.05B 3.6B 3.34B 3.04B 5.73B 385B 5.82B 40.12B 15.73B 201B 15.21B 14.88B EV / Sales 2027 *
0.16x
EV / Sales 2028 * 0.16x
Free-Float
87.33%
Yield 2027 *
2.39%
Yield 2028 * 2.65%
1 day+0.81%
1 week+5.81%
Current month+5.68%
1 month+4.38%
3 months+9.71%
6 months+11.39%
Current year+12.82%
1 week 2,981
Extreme 2981
3,131
1 month 2,904.5
Extreme 2904.5
3,182
Current year 2,530
Extreme 2530
3,182
1 year 2,456.5
Extreme 2456.5
3,182
3 years 2,156
Extreme 2156
3,182
5 years 1,603
Extreme 1603
3,182
10 years 1,426
Extreme 1426
3,182
Manager TitleAgeSince
Chief Executive Officer 65 2026-09-30
Chief Administrative Officer - 2025-05-31
Corporate Officer/Principal 69 2025-05-31
Director TitleAgeSince
Director/Board Member 63 2010-05-31
Director/Board Member 71 2007-05-31
Director/Board Member 54 2013-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.81%+5.81%+23.47%+27.63% 4.05B
+0.43%+6.59%+56.57%+106.64% 1,120B
+0.90%-2.25%+32.26%+63.73% 616B
+0.71%+3.24%+24.33%+91.33% 504B
-0.13%+5.98%+33.66%+50.18% 367B
+0.52%+0.24%+72.13%+40.11% 360B
-0.95%+4.70%+19.65%+42.71% 288B
-1.98%+3.73%-0.89%+10.43% 258B
-0.35%+4.25%+44.74%+52.06% 234B
-0.75%+3.32%+27.18%+94.07% 194B
Average -0.08%+3.83%+33.31%+57.89% 394.5B
Weighted average by Cap. +0.13%+3.83%+39.32%+71.78%

Financials

2027 *2028 *
Net sales 3,941B 24.96B 22.19B 20.56B 18.71B 35.31B 2,369B 35.87B 247B 96.92B 1,236B 93.68B 91.68B 4,055B 25.68B 22.83B 21.16B 19.25B 36.33B 2,437B 36.91B 254B 99.72B 1,272B 96.38B 94.33B
Net income 44.5B 282M 251M 232M 211M 399M 26.75B 405M 2.79B 1.09B 13.96B 1.06B 1.04B 45.89B 291M 258M 239M 218M 411M 27.59B 418M 2.88B 1.13B 14.4B 1.09B 1.07B
Net Debt - -
Projected Income Statement - Annual - MediPal Holdings Corporation
Logo MediPal Holdings Corporation
Medipal Holdings Corp is a Japan-based company principally engaged in the wholesale of pharmaceuticals, cosmetics, daily necessities, and veterinary medicines. The Company operates in three segments. The Prescription Pharmaceuticals Wholesale Business segment engages in wholesale business targeting customers such as hospitals, clinics, and dispensing pharmacies. The Cosmetics, Daily Necessities, and General Pharmaceuticals Wholesale Business segment engages in wholesale business targeting customers such as drugstores, home improvement centers, convenience stores, and supermarkets. The Veterinary Medicines and Food Processing Raw Materials Wholesale Business segment engages in wholesale business targeting customers such as veterinary hospitals, livestock and fisheries producers, and processed food manufacturers. The Company also engages in preventive medicine, research and development of cutting-edge medical technology, non-life insurance agency services, and others.
Employees
13,024
Date Price Change Volume
26-10-16 JP¥3,125.00 +0.81% 354,300
26-10-15 JP¥3,100.00 +1.87% 346,000
26-10-14 JP¥3,043.00 -0.33% 399,100
26-10-13 JP¥3,053.00 +3.37% 501,900
26-10-09 JP¥2,953.50 +0.15% 343,200
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - MediPal Holdings Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
3,125.00JPY
Average target price
3,145.00JPY
Spread / Average Target
+0.64%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - MediPal Holdings Corporation
  1. Stock Market
  2. Stocks
  3. 7459 Stock